Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook

radiopharmaceuticals

  • You have access
    First-in-human study of novel SSTR antagonist 177Lu-DOTA-LM3 for peptide receptor radionuclide therapy in patients with metastatic neuroendocrine neoplasms: dosimetry, safety and efficacy
    Richard P. Baum, Jingjing Zhang, Christiane Schuchardt, Dirk Mueller and Helmut Maecke
    Journal of Nuclear Medicine March 5, 2021, jnumed.120.258889; DOI: https://doi.org/10.2967/jnumed.120.258889
  • You have access
    Site-Specific and Residualizing Linker for 18F-Labeling with Enhanced Renal Clearance: Application to an Anti-HER2 Single Domain Antibody Fragment
    Zhengyuan Zhou, Rebecca Meshaw, Michael R Zalutsky and Ganesan Vaidyanathan
    Journal of Nuclear Medicine February 26, 2021, jnumed.120.261446; DOI: https://doi.org/10.2967/jnumed.120.261446
  • You have access
    Technological (R)Evolution Leads to Detection of More Sentinel Nodes in Patients with Melanoma in the Head and Neck Region
    Danique Berger, Nynke van den Berg, Vincent van der Noort, Bernies van der Hiel, Renato A. Valdés Olmos, Tessa A. Buckle, Gijs KleinJan, Oscar Roberto Brouwer, Lenka Vermeeren, Baris Karakullukçu, Michiel van den Brekel, Bart van der Wiel, Omgo E Nieweg, Alfons Balm, Fijs E van Leeuwen and Martin Klop
    Journal of Nuclear Medicine February 26, 2021, jnumed.120.246819; DOI: https://doi.org/10.2967/jnumed.120.246819
  • You have access
    Global Issues of Radiopharmaceutical Access and Availability: A Nuclear Medicine Global Initiative Project
    Cathy S. Cutler, Elizabeth Bailey, Vijay Kumar, Sally W. Schwarz, Hee-Seung Bom, Jun Hatazawa, Diana Paez, Pilar Orellana, Lizette Louw, Fernando Mut, Hiroki Kato, Arturo Chiti, Savvas Frangos, Frederic Fahey, Gary Dillehay, Seung J. Oh, Dong S. Lee, Sze-Ting Lee, Rodolfo Nunez-Miller, Guru Bandhopadhyaya, Prasanta K. Pradhan and Andrew M. Scott
    Journal of Nuclear Medicine March 1, 2021, 62 (3) 422-430; DOI: https://doi.org/10.2967/jnumed.120.247197
  • You have access
    Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Non-Human Primates
    Olivier Barret, Lei Zhang, David Alagille, Cristian C. Constantinescu, Christine Sandiego, Caroline Papin, Jenna M. Sullivan, Thomas Morley, Vincent M. Carroll, John Seibyl, Jianqing Chen, Chewah Lee, Anabella Villalobos, David Gray, Timothy J. McCarthy and Gilles Tamagnan
    Journal of Nuclear Medicine February 12, 2021, jnumed.120.256008; DOI: https://doi.org/10.2967/jnumed.120.256008
  • You have access
    Molecular Imaging: PARP-1 and Beyond
    Laura Puentes, Mehran Makvandi and Robert Henry Mach
    Journal of Nuclear Medicine February 12, 2021, jnumed.120.243287; DOI: https://doi.org/10.2967/jnumed.120.243287
  • You have access
    Combination of forced diuresis with additional late imaging in 68Ga-PSMA-11 PET/CT – effects on lesion visibility and radiotracer uptake
    Ian Alberts, Jan Niklas Huenermund, Christos Sachpekidis, Helle Damgaard Zacho, Clemens Mingels, Lotte Dijkstra, Karl Peter Bohn, Tilman Laeppchen, Eleni Gourni, Axel Rominger, Axel Rominger and Ali Afshar-Oromieh
    Journal of Nuclear Medicine February 5, 2021, jnumed.120.257741; DOI: https://doi.org/10.2967/jnumed.120.257741
  • You have access
    Utility of 211At-trastuzumab for the Treatment of Metastatic Gastric Cancer in the Liver: Evaluation of a Preclinical α-Radioimmunotherapy Approach in a Clinically-relevant Mouse Model
    Huizi Keiko Li, Yukie Morokoshi, Satoshi Kodaira, Tamon Kusumoto, Katsuyuki Minegishi, Hiroaki Kanda, Kotaro Nagatsu and SUMITAKA HASEGAWA
    Journal of Nuclear Medicine February 5, 2021, jnumed.120.249300; DOI: https://doi.org/10.2967/jnumed.120.249300
  • You have access
    First-in-Human Application of Terbium-161: A Feasibility Study Using 161Tb-DOTATOC
    Richard P. Baum, Aviral Singh, Harshad R. Kulkarni, Peter Bernhardt, Tobias Rydén, Christiane Schuchardt, Nadezda Gracheva, Pascal V. Grundler, Ulli Köster, Dirk Müller, Michael Pröhl, Jan Rijn Zeevaart, Roger Schibli, Nicholas Philip Van der Meulen and Cristina Müller
    Journal of Nuclear Medicine February 5, 2021, jnumed.120.258376; DOI: https://doi.org/10.2967/jnumed.120.258376
  • You have access
    Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone
    Inês F. Antunes, Rutger Dost, Hilde D. Hoving, Aren van Waarde, Rudi A. Dierckx, Douwe F. Samplonius, Wijnand Helfrich, Philip H Elsinga, Erik F de Vries and Igle J. de Jong
    Journal of Nuclear Medicine January 30, 2021, jnumed.120.253641; DOI: https://doi.org/10.2967/jnumed.120.253641

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire